nach oben

Erschienen in:

01.06.2019 | Case report

Canakinumab

Injection site reaction: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2019

Einloggen, um Zugang zu erhalten

Excerpt

In a retrospective study involving 47 patients, a patient [age and sex not stated] was described, who exhibited transient injection site reaction following administration of canakinumab injection [dosage not stated] for systemic juvenile idiopathic arthritis [duration of treatment to reaction onset not stated]. Concomitantly, the patient also received unspecified glucocorticoids. …

Pardeo M, et al. Canakinumab in systemic juvenile idiopathic arthritis: clinical inactive disease rate and safety initalian patients. Pediatric Rheumatology 17 (Suppl. 1): (plus oral presentation) abstr. P2062, May 2019. Available from: URL: http://doi.org/10.1186/s12969-019-0313-x [abstract] - Italy

Titel: Canakinumab
Injection site reaction: case report
Publikationsdatum: 01.06.2019
Verlag: Springer International Publishing
Erschienen in: Reactions Weekly / Ausgabe 1/2019
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-019-63955-x

Springer Medizin

Canakinumab

Injection site reaction: case report

Excerpt

Weitere Artikel der Ausgabe 1/2019

Hydroxycarbamide

Docetaxel

Anakinra

Bupivacaine

Trastuzumab

Aripiprazole

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Hydroxycarbamide

Docetaxel

Anakinra

Bupivacaine

Trastuzumab

Aripiprazole